Back to mobile site

Wedbush Assumes ImageneBio (IMA) at Underperform

November 25, 2025 6:22 AM EST Send to a Friend
Wedbush analyst Martin Fan assumes coverage on ImageneBio (NASDAQ: IMA) with a Underperform rating and a price target of $2.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login